Catalent 4Q Revenues: $519.6 million (+3%) 4Q Earnings: $27.2 million (+66%) FY Revenues: $1.8 billion (+2%) FY Earnings: $16.2 million (loss of $49.6 million FY13) Comments: Revenue from the Oral Technologies segment was $348.1 million, up 4% in the quarter led by the softgel business in international markets, and partially offset by volume declines in the pharma softgel business in North America and the company’s exit from its third-party commercial packaging business. Revenue from the De...